|
|
Volumn 11, Issue 13 Pt 2, 2005, Pages
|
|
Study design issues and early stage non-small cell lung cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADJUVANT CHEMOTHERAPY;
BIOASSAY;
CANCER STAGING;
CLINICAL TRIAL;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
METHODOLOGY;
ORGANIZATION AND MANAGEMENT;
PATHOLOGY;
PATIENT SELECTION;
PROGNOSIS;
REVIEW;
SURVIVAL;
TIME;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
ELIGIBILITY DETERMINATION;
ENDPOINT DETERMINATION;
HUMANS;
LUNG NEOPLASMS;
NEOPLASM STAGING;
PATIENT SELECTION;
PROGNOSIS;
RESEARCH DESIGN;
SURVIVAL ANALYSIS;
TIME FACTORS;
MLCS;
MLOWN;
|
|
EID: 24944562732
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: 10.1158/1078-0432.ccr-05-9003 Document Type: Review |
|
Times cited : (4)
|
|
References (8)
|
